The success of Viagra initially sparked a surge for major pharmaceutical companies, but recent shifts present a murky scenario for shareholders. Off-patent alternatives are eroding profits, and ongoing patent https://miriamqkdf909865.xzblogs.com/81519668/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-bet